LGP.ASX: Scheme Update

Scheme Update

Stock	Little Green Pharma Ltd (LGP.ASX)
Release Time	21 Apr 2026, 9:39 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Little Green Pharma Postpones Scheme Consideration

Key Points

Postponement of Scheme Consideration Resolution to 22 May 2026
Remaining Conditions Precedent need to be satisfied
Resolutions 2(a), 2(b) and 3 to be put to shareholders on 22 April 2026

Full Summary

Little Green Pharma Ltd (ASX: LGP) has announced that the LGP Board has resolved to postpone the consideration of resolution 1 regarding the approval of the issuance of the New LGP Ordinary Shares and the New LGP CV Shares in connection with the proposed acquisition of Cannatrek Ltd (Cannatrek) by way of scheme of arrangement (Scheme). The consideration of the Scheme Consideration Resolution will be postponed until 22 May 2026 at 3.30pm (Perth time). This is to allow the parties to satisfy the remaining Conditions Precedent for the Scheme, as outlined in the Scheme Booklet. The Company and Cannatrek do not anticipate any issues in achieving satisfaction of these Conditions. Resolutions 2(a), 2(b) and 3 will be put to LGP Shareholders at the General Meeting as scheduled for 22 April 2026. LGP will make a further announcement prior to 22 May 2026 to update LGP Shareholders regarding the consideration of the Scheme Consideration Resolution.